Invasive Breast Cancer
📧 Sign up to get email alerts when something new happens for Invasive Breast Cancer.
Sign up freeTop drugs studied for this disease
-
FDA label_change · 2016-01-25FDA Approved: EVISTA — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for Evista (raloxifene hydrochloride) filed by Eli Lilly, resulting in changes to the product labeli…